no more tirzepatide Weight regain after the withdrawal of (Zepbound) may wipe out many of the cardiometabolic gains made during weight loss, a post-hoc analysis of the SURMOUNT-4 trial indicated. Read at: https://www.medpagetoday.com/endocrinology/obesity The FDA says the Zepbound

When a provider writes a Mounjaro prescription with diagnosis code E66.01 (morbid obesity due to excess calories), the pharmacy claim is rejected because Mounjaro's FDA approval is for type 2 diabetes, not obesity

Steering clear of greasy, fried, or heavily spiced foods, as well as carbonated drinks, can also reduce nausea and bloating

Top stories:

These effects were generally mild to moderate and transient

The calorie math: why it matters more on tirzepatide Tirzepatide works partly because it reduces your total calorie intake

Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models